FEBS Open Bio, 2019 · DOI: 10.1002/2211-5463.12651 · Published: May 2, 2019
Spinal cord injury (SCI) often leads to neuronal apoptosis, a process where nerve cells die, contributing to neurological damage. However, autophagy, a cellular self-cleaning process, can help mitigate this damage by preventing apoptosis. This study explores how a long non-coding RNA called TCTN2 affects both apoptosis and autophagy in SCI. The researchers found that TCTN2 levels are reduced in SCI, while a microRNA called miR-216b is increased. By increasing TCTN2, they could reduce neuron apoptosis and trigger autophagy. TCTN2 appears to regulate miR-216b, promoting autophagy and reducing apoptosis through the miR-216b–Beclin-1 pathway. In a rat model of SCI, increasing TCTN2 improved neurological function. This suggests that TCTN2 can enhance autophagy, thereby reducing neuronal apoptosis and alleviating the effects of spinal cord injury.
TCTN2 could be a potential therapeutic target for SCI, as its overexpression promotes autophagy and reduces neuronal apoptosis.
TCTN2 expression levels could potentially serve as a prognostic marker for SCI, indicating the severity of the injury and the likelihood of recovery.
Modulating the miR-216b–Beclin-1 pathway, influenced by TCTN2, offers a novel approach to controlling neuronal apoptosis and improving neurological function after SCI.